advanced search

Welcome: Guest

log in

China Listed Real Estate Companies Report, 2006-Q12007

Publication Date June 2007
Publisher Research in China
Product Type Report
Pages 20
ISBN Number not applicable
Product Code RIC00105
Buy this product or for assistance call +44 20 7060 7474

Summary

In 2006, listed real estate enterprises realized prime operating revenue of RMB 92.748 billion and net profits of RMB 8.336 billion with a year-on-year increase of nearly 30% and 60% respectively. In the first quarter of 2007, such enterprises realized the prime operating revenue of RMB 21.01 billion and net profits of RMB 2.416 billion with an increase of 40% and 60% respectively from a year earlier. The prime operating costs of listed enterprises basically maintained the synchronized growth with the revenue with a gross margin stabilizing at around 30%. And profitability of real estate enterprises in 2006 and the first quarter of 2007 were very strong.

Selected Chats

  • Analysis on Profitability of Real Estate Enterprises, Q12006-2007
  • Prime Operating Costs and Expenses of Real Estate Enterprises, Q12006-2007
  • Cash Flow of Real Estate Enterprises, Q12006-2007
  • Advance receivable and Inventory Analysis of Real Estate Enterprises, Q12006-2007
  • Paying Proportion of Real Estate Enterprises, Q12006-2007
  • Performance Statistics of Real Estate Industry, 2006
  • Gross Margin and Earnings per Share in Real Estate Industry

Content

  • 1 Profitability of Real Estate Industry Increased Greatly
  • 2 Prime Operating Costs and Expenses were Controlled Appropriately
  • 3 Rapid Increase of the Industry Resulted in Intensity of Cash Supply
  • 4 Advance Receivable and Inventory Growth Guarantee Future Performance Increase
  • 5 Debt-paying Risk Reduced
  • 6 Investment Strategies in Real Estate Industry
Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>